Metildigoxin (C42H66O14) is a derivative of digoxin in which the hydroxyl group in the terminal β-position of digoxin is replaced by methoxy. Metildigoxin is metabolized to digoxin by demethylation and hydrolyzed to produce mono- and di-glycosides. As a cardiotonic drug, metildigoxin is characterized by good absorption in the negative gastrointestinal tract and fast onset of action. CD BioGlyco has an advanced lab to provide high-quality metildigoxin and metildigoxin tablet analysis services. We look forward to being your best assistant in Pharmaceutical Analysis.
Fig.1 The structural formula of metildigoxin. (CD BioGlyco)
Fig.2 Schematic diagram of metildigoxin analysis service. (CD BioGlyco)
Technology: Ultra-performance liquid chromatography/tandem mass spectrometry (UPLC-MS/MS), Solid-phase extraction (SPE), Liquid chromatography-mass spectrometry (LC-MS)
Journal: International Journal of Analytical Chemistry
Published: 2012
Results: In this study, a rapid and sensitive analytical method was developed for digoxin and metildigoxin analysis by UPLC-MS/MS. This new chromatographic method is very rapid, with a retention time of only 0.92 min for metildigoxin. At the same time, chromatography provides highly efficient separation and accurate quantification.
Fig.3 Multiple reaction monitoring chromatograms of whole blood samples spiked with different metildigoxins. (Melo, et al., 2012)
CD BioGlyco has an experienced analysis team to provide the most convenient and reliable Pharmaceutical and Biological analysis solutions. Our experienced analytical team provides the best solutions for our clients. Please feel free to contact us, and we will reply to you as soon as possible.
Reference
About Us
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.